Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis
Open Access
- 23 October 2015
- journal article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (10), e0141011
- https://doi.org/10.1371/journal.pone.0141011
Abstract
Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9 million people developed TB and 1.5 million people died from the disease. India constitutes 24% of the total TB burden. Early detection of TB cases is the key to successful treatment and reduction of disease transmission. Xpert MTB/RIF, an automated cartridge-based molecular technique detects Mycobacterium tuberculosis and rifampicin resistance within two hours has been endorsed by WHO for rapid diagnosis of TB. Our study is the first study from India with a large sample size to evaluate the performance of Xpert MTB/RIF assay in PTB samples. The test showed an overall sensitivity and specificity of 95.7% (430/449) and 99.3% (984/990) respectively. In smear negative-culture positive cases, the test had a sensitivity of 77.7%. The sensitivity and specificity for detecting rifampicin resistance was 94.5% and 97.7% respectively with respect to culture as reference standard. However, after resolving the discrepant samples with gene sequencing, the sensitivity and specificity rose to 99.0% and 99.3% respectively. Hence, while solid culture still forms the foundation of TB diagnosis, Xpert MTB/RIF proposes to be a strong first line diagnostic tool for pulmonary TB cases.This publication has 18 references indexed in Scilit:
- Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2013
- Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic studyBMC Infectious Diseases, 2013
- Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases2012
- Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary SpecimensJournal of Clinical Microbiology, 2011
- Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive studyThe Lancet Infectious Diseases, 2011
- Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?Journal of Clinical Microbiology, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Transmission of Drug‐Susceptible and Drug‐Resistant Tuberculosis and the Critical Importance of Airborne Infection Control in the Era of HIV Infection and Highly Active Antiretroviral Therapy RolloutsClinical Infectious Diseases, 2010
- Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2006
- Characterization of rifampin-resistance in pathogenic mycobacteriaAntimicrobial Agents and Chemotherapy, 1994